verified99%+ Verified Purity
local_shippingFast EU Delivery (through resellers)
Myotrope
Homechevron_rightAll Peptideschevron_rightCagrilintide Injection Pen
Cagrilintide Injection Pen
verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-cagrilintide-injection-pen-10mg

Official Product Data Sheet

Cagrilintide Injection Pen (10mg)

High >98% Purity

Vial Contents
10 mg Cagrilintide (3 mL pre-filled injection pen)
Includes
Ready-to-use multi-dose injection pen — no mixing required
Form
Pre-filled multi-dose pen
Purity
≥98%, third-party verified
Sequence
Amylin Analog
Molecular Formula
See chemical properties
Molecular Mass
4409 g/mol
CAS No.
1415456-99-3
Solubility
Concentration: ≈3.33 mg/mL | Per click: 1 unit ≈ 33.33 mcg (0.033 mg)
Storage
Refrigerate at 2–8 °C. Protect from light. Do not freeze.

Authorized Resellers

Available through our trusted partners

12
verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new
DE
verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new
View all authorized resellersshopping_cart
swipe_rightSwipe to see all tabs

Scientific Background

Cagrilintide is a long-acting amylin analog activating amylin receptors for satiety, gastric slowing, and appetite reduction via pathways entirely separate from GLP-1. The 10 mg pen at ≈3.33 mg/mL provides double the per-pen economy of the 5 mg format, ideal for longer protocols reaching 4.5 mg/week maintenance.

Intended Research Use

  • Amylin receptor activation and satiety research
  • Extended-duration GLP-1 combination protocols
  • Gastric emptying and food intake studies
  • Long-cycle obesity research at maintenance dose

menu_bookScientific Publications

article

N Engl J Med (2025)

Cagrilintide and Semaglutide — REDEFINE 1 Trial

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/39819825/

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Myotrope

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

Cagrilintide's amylin pathway is complementary to GLP-1 agonists and other metabolic peptides.

Semaglutide 10mg

Semaglutide 10mg (10mg vial)

arrow_forward

myo-semaglutide-10mg

The CagriSema combination — dual amylin + GLP-1 pathway activation achieving 24% average weight loss in REDEFINE trials.

Retatrutide 10mg

Retatrutide 10mg (10mg vial)

arrow_forward

myo-retatrutide-10mg

Triple-agonist power + amylin signaling for comprehensive metabolic coverage.

AOD-9604 5mg

AOD-9604 5mg (5mg vial)

arrow_forward

myo-hgh-fragment-aod-9604-5mg

Targeted fat breakdown alongside Cagrilintide's systemic appetite and satiety control.

schedule

Cycling Note: Typical protocol: 16–52 weeks with gradual 2-week titration steps.

Also Available

Cagrilintide 5mg
Vial

Cagrilintide

5mg

Cagrilintide 10mg
Vial

Cagrilintide

10mg

Cagrilintide Injection Pen 5mg
Pen

Cagrilintide Injection Pen

5mg